Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Problem is I don't see any news from the

Re: Problem is I don't see any news from the-

posted on Oct 05, 2009 11:45AM

Textron, Inc.

Total operating expense for 3 months ending 2009-07-04: $2.732B

That's why it's not news to Textron. Any payment to TPL and PTSC is the 3rd or 4th digit from the left on their quarterly expenses, a blip. If it were significant, they would be obligated to inform their shareholders.

It might be significant to PTSC/TPL, it might be big to you, but it isn't to Textron. To say otherwise is to be blatantly ignorant of scale.

Share
New Message
Please login to post a reply